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Background
Heterologous expression of α1,  β2 and  γ2S(γ1) subunits
produces a mixed population of GABAA receptors contain-
ing α1β2 or α1β2γ2S(γ1) subunits. GABA sensitivity (lower
in receptors containing γ1 or γ2S subunits) and the poten-
tiation of GABA-activated chloride currents (IGABA) by
benzodiazepines (BZDs) are dependent on γ2S(γ1) incor-
poration [1]. A variable γ subunit incorporation may
affect the estimation of IGABA potentiation by BZDs. We
propose an approach for estimation of BZD efficiency that
accounts for a mixed population of α1β2 and α1β2γ2S(γ1)
receptors.
Methods
We investigated the relation between GABA sensitivity
(EC50) and BZD modulation by analyzing triazolam-, clo-
tiazepam- and midazolam-induced potentiation of IGABA
in  Xenopus  oocytes under two-microelectrode voltage
clamp.
Results
Plotting EC50 versus BZD-induced shifts of GABA concen-
tration-response curves (ΔEC50(BZD)) of oocytes injected
with different amounts of α1, β2 and γ2S(γ1) cRNA (1:1:1-
1:1:10) revealed a linear regression between γ2S(γ1)-medi-
ated reduction of GABA sensitivity (EC50) and
ΔEC50(BZD). The slope factors of the regression were
always higher for oocytes expressing α1β2γ1 subunit recep-
tors (triazolam: 1.8 ± 0.1; clotiazepam: 1.6 ± 0.1; mida-
zolam: 2.3 ± 0.2) than for oocytes expressing α1β2γ2S
receptors (triazolam: 1.4 ± 0.1; clotiazepam: 1.4 ± 0.1;
midazolam: 1.3 ± 0.1). Mutant GABAA receptors (α1β2-
R207Cγ2S) with lower GABA sensitivity showed higher
drug efficiencies (slope factors: triazolam: 1.1 ± 0.1; clo-
tiazepam: 1.1 ± 0.1; midazolam: 1.2 ± 0.1) whereas higher
GABA sensitivity of α1-L263Sβ2γ2S mutant receptors was
associated with lower efficiency (slope factor: clo-
tiazepam: 1.7 ± 0.1).
Conclusion
Regression analysis enabled the estimation of BZD effi-
ciency when variable mixtures of α1β2 and  α1β2γ2S(γ1)
receptors are expressed and provided new insights into the
γ2S(γ1) dependency of BZD action. The method for deter-
mining the slope of the regression line also allowed the
determination of the percentage of α1β2γ2S  receptors.
Assuming a twofold difference in the single channel con-
ductance of α1β2 and α1β2γ2S receptors, at 70% current
ratio of γ2S-containig receptors our mathematical model
predicts only about 50% of γ2S subunit incorporation. Our
data suggest that BZDs reduce a γ-subunit-mediated inhi-
bition of GABA sensitivity.
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